醫(yī)院護理部壓瘡報表一(院外帶入壓瘡統(tǒng)計2023）,,,,,,,,

序號,指標名稱,計算公式,,一季度,二季度,三季度,四季度,全年

1.1,全部,分子,患者入院前有一處或多處壓瘡的總例次,31,35,41,32,139

,,分母,住院患者例數(shù),7220,8626,8021,8830,32697

,,分子/分母,﹪,0.43%,0.41%,0.51%,0.36%,0.43%

1.1.1,一級壓瘡,分子,患者入院前有一處或多處一級壓瘡的患者人次,2,1,2,3,8

,,分母,住院患者例數(shù),7220,8626,8021,8830,32697

,,分子/分母,﹪,0.03%,0.01%,0.02%,0.03%,0.02%

1.1.2,二級壓瘡,分子,患者入院前有一處或多處二級壓瘡的患者人次,29,27,36,43,135

,,分母,住院患者例數(shù),7220,8626,8021,8830,32697

,,分子/分母,﹪,0.40%,0.31%,0.45%,0.49%,0.41%

1.1.3,三級壓瘡,分子,患者入院前有一處或多處三級壓瘡的患者人次,0,2,1,3,6

,,分母,住院患者例數(shù),7220,8626,8021,8830,32697

,,分子/分母,﹪,0.00%,0.02%,0.01%,0.03%,0.02%

1.1.4,四級壓瘡,分子,患者入院前有一處或多處四級壓瘡的患者人次,2,4,2,3,11

,,分母,住院患者例數(shù),7220,8626,8021,8830,32697

,,分子/分母,﹪,0.03%,0.05%,0.02%,0.03%,0.03%

1.1.5,自家庭,分子,自家庭入住急性照護有一處或多處壓瘡的患者人次,30,35,36,27,128

,,分母,住院患者例數(shù),7220,8626,8021,8830,32697

,,分子/分母,﹪,0.42%,0.41%,0.45%,0.31%,0.39%

1.1.6,自養(yǎng)老院,分子,自養(yǎng)老院入住急性照護有一處或多處壓瘡的患者人次,0,0,0,0,0

,,分母,住院患者例數(shù),7220,8626,8021,8830,32697

,,分子/分母,﹪,0.00%,0.00%,0.00%,0.00%,0.00%

1.1.7,自其它醫(yī)院,分子,自其他醫(yī)院入住急性照護有一處或多處壓瘡的患者人次,1,0,3,5,9

,,分母,住院患者例數(shù),7220,8626,8021,8830,32697

,,分子/分母,﹪,0.01%,0.00%,0.04%,0.06%,0.03%

1.1.8,自其它來源,分子,自其他來源入住急性照護有一處或多處壓瘡的患者人次,0,0,2,0,2

,,分母,住院患者例數(shù),7220,8626,8021,8830,32697

,,分子/分母,﹪,0.00%,0.00%,0.02%,0.00%,0.01%

,,,,,,,,,

,,,,,,,,,

,,,,,,,,,

北京醫(yī)院護理部壓瘡報表二(住院期間壓瘡分級統(tǒng)計2023）,,,,,,,,

序號,指標名稱,計算公式,,一季度,二季度,三季度,四季度,全年

1.2,全部,分子,入住急性照護有一處或多處壓瘡的患者人次,6,11,11,15,43

,,分母1,入院時評估屬高風險患者例數(shù),247,246,558,327,1378

,,分母2,住院患者例數(shù),7220,8626,8021,8830,32697

,,分子/分母1,﹪,2.43%,4.47%,1.97%,4.59%,3.12%

,,分子/分母2,﹪,0.08%,0.13%,0.14%,0.17%,0.13%

1.2.1,一級壓瘡,分子,入住急性照護有一處或多處一級壓瘡的患者人次,0,5,0,5,10

,,分母1,入院時評估屬高風險患者例數(shù),247,246,558,327,1378

,,分母2,住院患者例數(shù),7220,8626,8021,8830,32697

,,分子/分母1,﹪,0.00%,2.03%,0.00%,1.53%,0.73%

,,分子/分母2,﹪,0.00%,0.06%,0.00%,0.06%,0.03%

1.2.2,二級壓瘡,分子,入住急性照護有一處或多處二級壓瘡的患者人次,6,5,10,19,40

,,分母1,入院時評估屬高風險患者例數(shù),247,246,558,327,1378

,,分母2,住院患者例數(shù),7220,8626,8021,8830,32697

,,分子/分母1,﹪,2.43%,2.03%,1.79%,5.81%,2.90%

,,分子/分母2,﹪,0.08%,0.06%,0.12%,0.22%,0.12%

1.2.3,三級壓瘡,分子,入住急性照護有一處或多處三級壓瘡的患者人次,0,1,1,0,2

,,分母1,入院時評估屬高風險患者例數(shù),247,246,558,327,1378

,,分母2,住院患者例數(shù),7220,8626,8021,8830,32697

,,分子/分母1,﹪,0.00%,0.41%,0.18%,0.00%,0.15%

,,分子/分母2,﹪,0.00%,0.01%,0.01%,0.00%,0.01%

1.2.4,四級壓瘡,分子,入住急性照護有一處或多處四級壓瘡的患者人次,0,0,0,0,0

,,分母1,入院時評估屬高風險患者例數(shù),247,246,558,327,1378

,,分母2,住院患者例數(shù),7220,8626,8021,8830,32697

,,分子/分母1,﹪,0.00%,0.00%,0.00%,0.00%,0.00%

,,分子/分母2,﹪,0.00%,0.00%,0.00%,0.00%,0.00%

,,,,,,,,,

,,,,,,,,,

,,,,,,,,,

,,,,,,,,,

,,,,,,,,,

,,,,,,,,,

,,,,,,,,,

,,,,,,,,,

北京醫(yī)院護理部壓瘡報表三(住院期間壓瘡部位統(tǒng)計2023）,,,,,,,,

序號,指標名稱,計算公式,,一季度,二季度,三季度,四季度,全年

1.3,全部,分子,入住急性照護有一處或多處壓瘡的患者人次,6,11,11,15,43

,,分母1,入院時評估屬高風險患者住院總床日數(shù),2483,2567,5758,3441,14249

,,分母2,住院總床日數(shù),72581,90826,92816,87857,344080

,,分子/分母1,﹪,0.24%,0.43%,0.19%,0.44%,0.30%

,,分子/分母2,﹪,0.0083%,0.0121%,0.0119%,0.0171%,0.0125%

1.3.1,骶尾椎骨處,分子,同一次住院期間發(fā)生骶尾椎骨處所有級別壓瘡的患者人次,6,8,8,11,33

,,分母1,入院時評估屬高風險患者住院總床日數(shù),2483,2567,5758,3441,14249

,,分母2,住院總床日數(shù),72581,90826,92816,87857,344080

,,分子/分母1,﹪,0.24%,0.31%,0.14%,0.32%,0.23%

,,分子/分母2,﹪,0.0083%,0.0088%,0.0086%,0.0125%,0.0096%

1.3.2,坐骨處,分子,同一次住院期間發(fā)生坐骨處所有級別壓瘡的患者人次,0,0,0,1,1

,,分母1,入院時評估屬高風險患者住院總床日數(shù),2483,2567,5758,3441,14249

,,分母2,住院總床日數(shù),72581,90826,92816,87857,344080

,,分子/分母1,﹪,0.00%,0.00%,0.00%,0.03%,0.01%

,,分子/分母2,﹪,0.0000%,0.0000%,0.0000%,0.0011%,0.0003%

1.3.3,股骨粗隆處,分子,同一次住院期間發(fā)生股骨粗隆處所有級別壓瘡的患者人次,0,1,3,4,8

,,分母1,入院時評估屬高風險患者住院總床日數(shù),2483,2567,5758,3441,14249

,,分母2,住院總床日數(shù),72581,90826,92816,87857,344080

,,分子/分母1,﹪,0.00%,0.04%,0.05%,0.12%,0.06%

,,分子/分母2,﹪,0.0000%,0.0011%,0.0032%,0.0046%,0.0023%

1.3.4,跟骨處,分子,同一次住院期間發(fā)生跟骨處所有級別壓瘡的患者人次,1,1,0,3,5

,,分母1,入院時評估屬高風險患者住院總床日數(shù),2483,2567,5758,3441,14249

,,分母2,住院總床日數(shù),72581,90826,92816,87857,344080

,,分子/分母1,﹪,0.04%,0.04%,0.00%,0.09%,0.04%

,,分子/分母2,﹪,0.0014%,0.0011%,0.0000%,0.0034%,0.0015%

1.3.5,足踝處,分子,同一次住院期間發(fā)生足踝處所有級別壓瘡的患者人次,0,0,0,0,0

,,分母1,入院時評估屬高風險患者住院總床日數(shù),2483,2567,5758,3441,14249

,,分母2,住院總床日數(shù),72581,90826,92816,87857,344080

,,分子/分母1,﹪,0.00%,0.00%,0.00%,0.00%,0.00%

,,分子/分母2,﹪,0.0000%,0.0000%,0.0000%,0.0000%,0.0000%

北京醫(yī)院護理部壓瘡報表四(住院期間壓瘡部位統(tǒng)計2023）,,,,,,,,

序號,指標名稱,計算公式,,一季度,二季度,三季度,四季度,全年

1.3.6,肩胛骨處,分子,同一次住院期間發(fā)生肩胛骨處所有級別壓瘡的患者人次,0,1,0,1,2

,,分母1,入院時評估屬高風險患者住院總床日數(shù),2483,2567,5758,3441,14249

,,分母2,住院總床日數(shù),72581,90826,92816,87857,344080

,,分子/分母1,﹪,0.00%,0.04%,0.00%,0.03%,0.01%

,,分子/分母2,﹪,0.0000%,0.0011%,0.0000%,0.0011%,0.0006%

1.3.7,枕骨處,分子,同一次住院期間發(fā)生枕骨處所有級別壓瘡的患者人次,0,1,0,0,1

,,分母1,入院時評估屬高風險患者住院總床日數(shù),2483,2567,5758,3441,14249

,,分母2,住院總床日數(shù),72581,90826,92816,87857,344080

,,分子/分母1,﹪,0.00%,0.04%,0.00%,0.00%,0.01%

,,分子/分母2,﹪,0.0000%,0.0011%,0.0000%,0.0000%,0.0003%

1.3.8,其他部位,分子,同一次住院期間發(fā)生其他部位所有級別壓瘡的患者人次,0,0,11,4,15

,,分母1,入院時評估屬高風險患者住院總床日數(shù),2483,2567,5758,3441,14249

,,分母2,住院總床日數(shù),72581,90826,92816,87857,344080

,,分子/分母1,﹪,0.00%,0.00%,0.19%,0.12%,0.11%

,,分子/分母2,﹪,0.0000%,0.0000%,0.0119%,0.0046%,0.0044%

1.3.9,多處壓瘡,分子,同一次住院期間發(fā)生二處（含）所有級別壓瘡的患者人次,1,5,2,3,11

,,分母,同一次住院期間發(fā)生一處或多處所有級別壓瘡的患者人次,6,11,11,12,40

,,分子/分母,﹪,16.67%,45.45%,18.18%,25.00%,27.50%

北京醫(yī)院護理部壓瘡報表五(重癥患者住院期間壓瘡統(tǒng)計2023）,,,,,,,,

序號,指標名稱,計算公式,,一季度,二季度,三季度,四季度,全年

1.4,全部,分子,ICU+RCU+CCU+A02分子之和,2,3,3,5,13

,,分母,ICU+RCU+CCU+A02分母之和,128,135,165,168,596

,,分子/分母,﹪,1.56%,2.22%,1.82%,2.98%,2.18%

1.4.1,ICU,分子,入住ICU期間有一處或多處壓瘡的患者人次,2,3,2,4,11

,,分母,ICU患者例數(shù),29,30,30,38,127

,,分子/分母,﹪,6.90%,10.00%,6.67%,10.53%,8.66%

1.4.2,RCU,分子,入住RCU期間有一處或多處壓瘡的患者人次,0,0,0,1,1

,,分母,RCU患者例數(shù),12,21,33